Clinical trials recruiting in Hixson, Tennessee

Phase breakdown

Conditions recruiting in Hixson, Tennessee

Recruiting trials in Hixson, Tennessee

• AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
  NCT06991114 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
  NCT03418961 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
  NCT03723928 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
  NCT06527872 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Hixson, Tennessee?

4 recruiting trials have at least one study site in Hixson, Tennessee.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.